Please try another search
vTv Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 1 million. Net loss was USD 4.87 million compared to USD 4.5 million a year ago. Basic loss per share from continuing operations was USD 1.17 compared to USD 2.16 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 1 | |||
Gross Profit | -1.65 | -2.14 | -2.82 | -4.69 |
Operating Income | -5.63 | -4.71 | -5.37 | -8 |
Net Income | -4.86 | -3.48 | -6.65 | -5.62 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 54.18 | 11.02 | 14.92 | 22.43 |
Total Liabilities | 28.2 | 29.57 | 29.44 | 28.83 |
Total Equity | 25.99 | -18.55 | -14.51 | -6.4 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -7.34 | -2.91 | -4.83 | -6.17 |
Cash From Investing Activities | 4.4 | |||
Cash From Financing Activities | 50.14 | -0.282 | 0.473 | 0 |
Net Change in Cash | 42.81 | 1.21 | -4.36 | -6.17 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review